Langsford et al. Am J Nephrol 2017;45: (DOI: / )

Slides:

Advertisements

Similar presentations

Slides courtesy of Matt Hall Nottingham University Hospitals February 2011 Slides courtesy of Matt Hall Nottingham University Hospitals February 2011 Slides.

Advertisements

ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)

6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.

Am J Kidney Dis. 2014;63(6): R3 박세정 /prof. 이태원 Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced.

© 2016 S. Karger AG, Basel. All rights reserved Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency.

Lacto-ovo vegetarian group

A.M. Thompson, T.G. Pickering Kidney International

Am J Nephrol 2013;38: DOI: / Fig. 1. Study selection process.

Three Decades of Atherosclerotic Reno-vascular Disease Management - Changing Outcomes in an Observational Study Kidney Blood Press Res 2016;41:

The Clinical Significance of Uric Acid and Complement Activation in the Progression of IgA Nephropathy Kidney Blood Press Res 2016;41: DOI: /

Renal Parenchymal Hypoxia, Hypoxia Response and the Progression of Chronic Kidney Disease Am J Nephrol 2008;28:998– DOI: / © 2008.

All-cause mortality by treatment group

Chronic Kidney Disease in Diabetes

Diabetic Cardiovascular Disease Predicts Chronic Kidney Disease Awareness in the Kidney Early Evaluation Program Cardiorenal Med 2011;1:45–52 - DOI: /

Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients Am J Nephrol 2017;45: DOI: /

Effect of Food Insecurity on Chronic Kidney Disease in Lower-Income Americans Am J Nephrol 2014;39: DOI: / Fig. 1. Age-adjusted.

Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study Am J Nephrol 2016;43:

Fig. 1. Intrarenal resistance index (RI) by stage of CKD (classification followed the K/DOQI guidelines [ 2 ]). Each box shows the median, quartiles and.

Associations of renal impairment (adjusted odds ratio and 95% CI) and the presence of individual small vessel disease markers stratified by age. Associations.

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et.

Relative mortality risk associated with quartiles of systolic blood pressure compared with systolic

Systolic Blood Pressure Intervention Trial (SPRINT)

Fan et al. Am J Nephrol 2017;45: (DOI: / )

The percentage of subjects with de novo development of renal function impairment (GFR

SAVE: Risk of total mortality associated with reduced kidney function

Kuwabara et al. Am J Nephrol 2017;45: (DOI: / )

Bhandari et al. Am J Nephrol 2017;45: (DOI: / )

The effect of acute kidney injury after revascularization on the development of chronic kidney disease and mortality in patients with chronic limb ischemia

Using Laboratory Test Results at Hospital Admission to Predict Short-term Survival in Critically Ill Patients With Metastatic or Advanced Cancer Lee.

Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients Sharma et al. Am J Nephrol 2016;44: (DOI: / )

Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology.

Simple Cysts in Donor Kidney Contribute to Reduced Allograft Function

Early Systolic Blood Pressure Changes in Incident Hemodialysis Patients Are Associated with Mortality in the First Year Kidney Blood Press Res 2012;35:663–670.

Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease Torres et al. Am J.

Hammoud et al. Am J Nephrol 2016;44: (DOI: / )

Volume 68, Issue 6, Pages (December 2015)

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients G.A. Block, P. Raggi, A. Bellasi, L. Kooienga,

Medical Nutrition Therapy for Chronic Kidney Disease Improves Biomarkers and Slows Time to Dialysis Desirée de Waal, MS, RD, CD, FAND, Emily Heaslip,

A: Kaplan-Meier estimate of time to first LLA

A Pathological Scoring System to Predict Renal Outcome in Diabetic Nephropathy Am J Nephrol 2015;41: DOI: / Fig. 1. Renal survival.

Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study Digsu.

Fung TT, et al. Circulation 2009;119:

The effect of acute kidney injury after revascularization on the development of chronic kidney disease and mortality in patients with chronic limb ischemia

Volume 86, Issue 4, Pages (October 2014)

Volume 88, Issue 2, Pages (August 2015)

Volume 79, Issue 12, Pages (June 2011)

C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go

Volume 91, Issue 1, Pages (January 2017)

Baseline Characteristics of Cardiovascular Risk Factors and Selected Dietary Variables in a Cohort of 22,881 Men and 35,091 Women to Quintile of Fish Intakes.

Payan Schober et al. Am J Nephrol 2017;45: (DOI: / )

Survival by time of day of hemodialysis: analysis of United States renal data system dialysis morbidity and mortality waves III/IV Kevin C Abbott, MD,

Nowak et al. Am J Nephrol 2016;44: (DOI: / )

Kaplan-Meier plots of hHF: DPP-4i and SU cohort with baseline CVD (panel A); saxagliptin and sitagliptin cohorts with baseline CVD (panel B); DPP-4i and.

Targeting Immunity in End-Stage Renal Disease

Volume 61, Issue 2, Pages (February 2002)

Kaplan-Meier curve of cumulative percentage of cardiac mortality by peak flow rate category (adjusted HRs (95% CI) compared with ≥550 L/min: (

Volume 75, Issue 1, Pages (January 2009)

Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa

Kaplan-Meier estimation of diabetes-related survival curves in patients grouped according to increased 24-h proteinuria (A), the presence of preexisting.

Adjusted HRs (95% CIs) for all-cause mortality associated with BMI by smoking status in men and women and by CHD, type 2 diabetes, and cancer status at.

Adjusted HRs (95% CIs) for all-cause mortality associated with body fat percentage by smoking status in men and women and by CHD, type 2 diabetes, and.

Baseline predictors for risk of cardiovascular events or all-cause mortality among immigrants with language barriers (N = 87,707). *Adjustment for all.

Multivariate-adjusted HRs (95% CI) for deaths from CV disease (CVD), coronary heart disease (CHD), stroke, and all-cause mortality according to fasting.

Kaplan-Meier survival curve for CVD mortality among physically active and inactive type 2 diabetic patients stratified by baseline hs-CRP levels. Kaplan-Meier.

Kaplan-Meier survival analysis for all-cause and CVD mortality in 2,823 type 2 diabetic patients stratified by CKD according to each creatinine-based equation.

Correlations among chronic kidney disease (CKD) classification, urinary adiponectin level, eGFR, and ACR. (A) Correlation between CKD classification and.

Fistula and Survival Outcomes after Fistula Creation among Predialysis Chronic Kidney Disease Stage 5 Patients Miyamoto et al. Am J Nephrol 2017;45:

HR for mortality in ischemic heart disease.

Adjusted HRs for death from any cause and death from specific causes among patients with type 1 diabetes. Adjusted HRs for death from any cause and death.

Presentation transcript:

The Association between Biomarker Profiles, Etiology of Chronic Kidney Disease, and Mortality Langsford et al. Am J Nephrol 2017;45:226-234 (DOI:10.1159/000454991) Table 1. Baseline demographic, renal-specific data and biomarker profiles by CKD etiological groups

The Association between Biomarker Profiles, Etiology of Chronic Kidney Disease, and Mortality Langsford et al. Am J Nephrol 2017;45:226-234 (DOI:10.1159/000454991) Fig. 1. Kaplan-Meier analysis of survival stratified by CKD etiology. GN, glomerulonephritis; PCK/TIN, polycystic kidney disease, pyelonephritis, or chronic tubulointerstitial nephritis; DKD, diabetic kidney disease.

The Association between Biomarker Profiles, Etiology of Chronic Kidney Disease, and Mortality Langsford et al. Am J Nephrol 2017;45:226-234 (DOI:10.1159/000454991) Table 2. Multivariate HRs (95% CIs) of traditional risk factors for mortality by CKD etiological groups

The Association between Biomarker Profiles, Etiology of Chronic Kidney Disease, and Mortality Langsford et al. Am J Nephrol 2017;45:226-234 (DOI:10.1159/000454991) Fig. 2. Biomarker profiles associated with an increased risk of mortality stratified by CKD etiology. Adjusted for statistically significant recognized risk factors: DKD: age, history of CVD, eGFR at cohort entry, diastolic blood pressure, and albumin; GN: age; PCK/TIN: age and diastolic blood pressure. Shaded plots, p < 0.05.